Trial reportNeurosurgical review2025
Comparing surgical outcomes of the semisitting versus lateral position in large vestibular schwannoma surgery: a randomized clinical trial.
Trial report in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The choice between the semisitting position (SSP) and the lateral position (LP) for vestibular schwannoma (VS) surgery remains a topic of debate, particularly for large tumors, and high-quality evidence is limited. This study aimed to prospectively determine the optimal surgical position for VS with a diameter of ≥ 3 cm. This analysis is based on a randomized clinical trial assessing the efficacy and safety of VS surgery in SSP versus LP. Outcomes included the extent of resection, functional results, complications, and health economics. A total of 115 consecutive patients with large VS were prospectively enrolled between December 2019 and November 2023 (SSP: 58, LP: 57). The gross-total resection (GTR) rate was significantly higher in the SSP group compared to the LP group (P = 0.026). There was no significant difference in facial nerve (FN) function between the groups 7 days post-operation; however, FN function was superior in the LP group after 1 year. Preoperative preparation duration and craniotomy durations in the SSP group were significantly longer, while overall operative time, tumor resection, and cranial closure durations showed no significant differences between the groups. In terms of health economics, patients in the SSP group had longer hospital stays and higher hospitalization costs. This study demonstrated that SSP offers advantages in achieving higher GTR rates. However, it does not provide any significant benefit in preserving facial nerve function. Given the elevated risks of VAE, SSP should primarily be considered for patients in good physical condition. Furthermore, patients in the SSP group required more extensive preoperative evaluations and intensive monitoring, resulting in longer hospital stays and increased costs. The financial implications of hospitalization should also be taken into account.
Indexed as
Identifiers
40451962What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.